Show Summary Details
Page of

Antidepressants I: Selective Serotonin Reuptake Inhibitors 

Antidepressants I: Selective Serotonin Reuptake Inhibitors
Antidepressants I: Selective Serotonin Reuptake Inhibitors

Paul E. Croarkin

, Graham J. Emslie

, and Taryn L. Mayes

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 04 December 2021

Chapter 20 discusses selective serotonin reuptake inhibitors (SSRIs), which are among the most frequently prescribed psychotropic medications in child and adolescent psychiatry, and addresses the beneficial effects in treatment of obsessive compulsive disorder (OCD), anxiety disorders, and major depressive disorder (MDD), potential use in pain disorders, eating disorders, and trichotillomania. Currently, there is limited pharmacokinetic data to guide dosing and practice in this age group.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.